Attana selected as one of seven companies listed at the Nordic Growth Market to present at the NGM "The Break Of A New Dawn" on Wednesday June 17[th]

The Corona pandemic has increased the rate of technological breakthroughs and transformations from years to a couple of months. The Nordic Growth Market, a part of Börse Stuttgart, has invited seven interesting growth companies to present their way forward.

Attana will present how our techology and knowledge is and can be applied for determination of immunity and elucidate it with examples from the ongoing diagnostic and therpeutic research at Prof. Ian Nicholls laboratory at the Linnaeus University.

For more information, please contact:

Teodor Aastrup, CEO Attana AB
tel: + 46 8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share prices, but is of general interest for the shareholders and hence should be communicated.

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit or contact